Grapefruit USA, Inc. (GPFT)

0.0014 0.0000 (0.00%) As of 12:57PM EDT. Market open.

Grapefruit USA, Inc.

1000 Northwest Street
Suite 1200-3094 Mid-Town Brandy Wine
Wilmington, DE 19801
United States
310 575 1175
https://www.grapefruitblvd.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 9

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Bradley J. Yourist	Chairman of the Board, CEO & President	180k	N/A	1970
Mr. Daniel J. Yourist	COO, Corporate Secretary & Director	180k	N/A	1968
Mr. Kenneth J. Biehl	Executive VP & CFO	N/A	N/A	1954
Beth Jones	Chief Compliance Officer	N/A	N/A	N/A
Chantel Lee	Head of Sales & Marketing	N/A	N/A	N/A

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Grapefruit USA, Inc. operates as a manufacturer and distributor of cannabis products in California. It primarily provides Hourglass, a time release THC+CBD-infused topical cream through online store. The company was formerly known as Grapefruit Boulevard Investments, Inc. and changed its name to Grapefruit USA, Inc. in January 2020. Grapefruit USA, Inc. was founded in 2017 and is based in Wilmington, Delaware.

Corporate governance

Grapefruit USA, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.